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Abstract
Seasonal variation in the infection rate with certain Gram-negative organisms has been previously described, but few studies have been
published regarding Escherichia coli. The aim of this study was to investigate the incidence rate of E. coli bloodstream infection (BSI) and
the association with temperature in different seasons in the Yizrael Valley. Positive blood cultures sent to the microbiology laboratory
of Ha’Emek Medical Centre over a period of 8 years (January 2001 to December 2008) were included. The mean monthly tempera-
ture in the Yizrael Valley in the same period was compared with the monthly E. coli BSI rate. We divided the year into three periods:
winter (December to February: mean temperature <15C), transitional (March, April and November: mean temperature 15–19C) and
summer (May to October: mean temperature ‡20C). In addition, we correlated the mean monthly antibiotic use in the same period
measured as total deﬁned daily doses for the whole regional population with E. coli BSI. During the study period, 2810 BSIs were
recorded (35% E. coli). In 67.4% of the cases of E. coli bacteraemia, the source was urinary tract infection. The crude incidence of
E. coli BSI was 4.1/1000 admissions. There was no difference in the number of cultures/month (mean: 29 ± 6). However, E. coli BSI
was 19% and 21% more frequent in summer than in the transitional and winter seasons, respectively (p 0.01). The antibiotic consump-
tion was signiﬁcantly higher in the winter period. We found signiﬁcantly higher rates of E. coli BSI in the summer period. Host, bacte-
rial and ecological factors, together with high consumption of antibiotics during the winter season, could partially explain these
ﬁndings.
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Introduction
Bacteraemia is a leading cause of morbidity and mortality
[1]. Gram-negative rods in general and Escherichia coli in par-
ticular are the most prevalent isolates in community-
acquired bloodstream infection (BSI) [2]. The epidemiology,
reservoir and principal routes by which humans are exposed
to these pathogenic strains of E. coli remain poorly under-
stood [3].
Recognition of seasonal trends in infectious diseases may
improve diagnosis, use of empirical therapy, and infection
control interventions [4].
Seasonal variation in rates of infection with certain
Gram-negative organisms has been previously described
[4–7]; furthermore, a seasonal variation in E. coli BSI was
recently demonstrated in a population-based study [5].
The aims of the study were:
1. To compare the incidence rates (IRs) of E. coli BSI at
Ha’Emek Medical Centre, between the winter, transi-
tional and summer seasons, during a 96-month period
(January 2001 to December 2008).
2. To examine the association between the IRs of E. coli
BSI and average temperature in the same seasons and
periods.
3. To examine the association between the IRs of E. coli
BSI and average monthly antimicrobial use in the com-
munity in the same seasons and periods, as a possible
factor that could inﬂuence the number of hospitalized
patients suffering from an infectious disease.
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Materials and Methods
The study was conducted at Ha’Emek Medical Centre, a
community university-afﬁliated medical centre in northern
Israel (500 beds), serving a population of 500 000 inhabit-
ants.
From January 2001 to December 2008, all positive E. coli
blood cultures obtained from adult patients (‡18 years old)
were prospectively recorded, as part of an ongoing BSI
surveillance programme conducted in our hospital. Only one
isolate was included for each bacteraemic episode. The
crude IR of E. coli BSI was calculated per 1000 hospital
admissions.
The temperature in the Yizrael Valley in the same period
was obtained from the Israeli Meteorological Service, who
provide a monthly report of minimal, maximal and average
temperatures at two locations in northern Israel, Nir
Ha’Emek and Nave Yaar, which are representative of the
regional weather.
In order to discriminate warm from cold months, we
divided the year into three ‘seasons’: winter (December to
February: mean temperature <15C), transitional (March,
April and November: mean temperature 15–19C) and sum-
mer (May to October: mean temperature ‡20C).
In addition, we correlated the mean monthly antibiotic
use between January 2001 and December 2008, measured as
total deﬁned daily dose (DDD) for the whole regional popu-
lation insured in ‘Clalit Health Services’, the largest medical
health organization in Israel, with 70% coverage for the pop-
ulation in our region.
The study was approved by the institutional ethics com-
mittee.
All statistical analyses were performed with SPSS soft-
ware, version 16 (SPSS Inc., Chicago, IL, USA). Poisson gen-
eralized linear models were used to estimate the association
of the number of E. coli BSIs per month with season. The
log of the number of hospital admissions in each month was
treated as an offset in the model, and a constant dispersion
over time was assumed. The association of the number of
E. coli infections per month with season was adjusted for the
number of months since January 2001, in order to account
for long-term trends and unmeasured time-related variables.
The Wald v2-test was used to assess seasonality. The associ-
ation of the number of E. coli BSIs per month with tempera-
ture was assessed by stratifying the data into summer and
non-summer months. This was also adjusted for the number
of months since January 2001. The Wald v2-test was used
to assess temperature. One-way ANOVA was performed to
assess whether there was a seasonal variation in the number
of admissions or the number of cultures. Similarly, one-way
ANOVA was performed to assess whether there was a
monthly variation in the number of cultures. Linear, qua-
dratic and cubic curves were ﬁtted to the data in order to
assess the existence of a time trend. Spearman correlations
were performed between monthly DDD and monthly tem-
perature and E. coli incidence.
Results
From January 2001 to December 2008, 239 232 patients
were hospitalized. The mean number of admissions per
month was similar in each season: 2540 in the winter season,
2475 in the transitional season, and 2476 in the summer sea-
son (difference not signiﬁcant). In this 96-month period,
2810 positive blood cultures were recovered (only the ﬁrst
blood culture for each patient/episode was included). Sixty-
ﬁve per cent of them (n = 1827) were non-E. coli, and 35%
(n = 983) were E. coli isolates; 72.4% of them were E. coli
acquired in the community, and 27.6% were hospital-
acquired BSIs. The most common source of E. coli BSI was
the urinary tract (67.4%).
The mean number of BSIs was 29 ± 6/month; there was
no statistically signiﬁcant difference in the number of cultures
per month.
The incidence of E. coli BSI (per 1000 admissions) per
month plotted over time, among hospitalized patients at
Ha’Emek medical centre, appeared to be stable over time
(Fig. 1), with a crude IR of E. coli BSI of 4.1/1000 hospital
admissions.
The mean temperature during the years 2001–2008 was
20.4 ± 5.9C (median: 20.6C). The hottest month was
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FIG. 1. The incidence of Escherichia coli bloodstream infections (per
1000 admissions) per month plotted over time, among hospitalized
patients at Ha’Emek medical centre.
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August, with a mean temperature of 28 ± 0.3C, and the
coldest month was January, with a mean temperature of
11.8 ± 1.2C. The temperatures measured in the deﬁned
‘seasons’ wereas follows: winter, <15C; transitional, 15–
19C; and summer, ‡20C.
The number of E. coli BSIs was signiﬁcantly higher in the
summer season than in either the winter season (31 ± 6 vs.
27 ± 4, respectively; p <0.01) or the transitional season
(31 ± 6 vs. 28 ± 6, respectively; p <0.03).
The IR ratio (IRR) for E. coli BSI according to season was
1.19 (95% CI 1.12–1.26) for comparison of the summer with
the transitional season, and 1.21 (95% CI 1.16–1.28) for
comparison of the summer season with the winter season;
that is, a means of 19% and 21% higher frequency in the
summer than in the transitional and the winter seasons,
respectively (p 0.01) (Fig. 2). No difference was found
between the transitional and winter seasons. Temperature
was positively correlated with the rate of E. coli BSI (Spear-
man r = 0.299; p <0.003). However, within seasons, no asso-
ciation between temperature and E. coli BSI rates were
found (p >0.60).
The average monthly antimicrobial use in the community
was 214 893 DDD; the highest use was in January
(258 324 DDD), and the lowest in July (191 595 DDD). The
expectedly higher use during the winter period was signiﬁ-
cantly negatively correlated with temperature (Spearman
r = )0.453, p <0.03), but was not correlated with the inci-
dence of all E. coli BSIs (Spearman r = )0.12, p >0.58)
(Fig. 3).
Discussion
There have been few reports of seasonal variation in the
incidence of BSI in hospitalized patients, and most of them
have been limited to intensive-care units [4].
Seasonal peaks in the IR of BSI caused by some Gram-neg-
ative organisms during the summer have been previously
described, including for Acinetobacter and Aeromonas [4,6,7].
Furthermore, seasonal variation of the most common Gram-
negative rods causing human infection, such as E. coli [5] and
Klebsiella pneumoniae, [8], was recently reported. Interest-
ingly, there have been no reports of summer peaks in the
incidence of infection caused by Gram-positive pathogens
[4]. Potential explanations for the summer and temperature-
associated peaks in the incidence of infection caused by
Gram-negative pathogens are many but unproven [4].
After 8 years of analysis of BSI in 239 232 hospitalized
patients, we found 2810 positive blood cultures equally dis-
tributed over the year (29 ± 6/month); however, the IRR for
E. coli according to season was signiﬁcantly higher in the
summer season, being 19% higher than in the transitional
season, and 21% higher than in the winter season, similarly
to what was reported by Perencevich et al. [4]. The temper-
ature gaps between the summer season and transitional
and winter seasons were 1–4C, and ‡5C, respectively.
Al-Hasan et al. [5] estimated that a 7% increase in the aver-
age monthly incidence of E. coli BSI occurred for every 5.5C
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FIG. 2. Monthly unadjusted incidence rate per 1000 admissions for
Escherichia coli bloodstream infection among hospitalized patients at
Ha’Emek Medical Centre, and the mean monthly temperature in the
region served by the medical centre.
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FIG. 3. Average monthly distribution of
Escherichia coli bloodstream infections,
antimicrobial community use measured
as total deﬁned daily dose (DDD), and
mean temperature.
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increase in average monthly temperature, which is similar to
our ﬁndings.
The exact cause of the observed higher rates of E. coli BSI
during warm months remains elusive [8]. It is reasonable to
hypothesize that humans also have higher levels of coloniza-
tion with environmental bacteria during warm months, and
higher colonization levels may explain the observed increase
in infection rate during the summer [8].
Researchers at the University of Minnesota reported a
higher density of E. coli in template soils from Lake Supe-
rior during the warmest months than in the remainder of
the year. This ecological association may provide a logical
hypothetical explanation for the increased rate of human
colonization with pathological strains of E. coli during the
warmest months, and hence an increased rate of infection
[9].
Although it is plausible that increased contamination of
food and water sources with E. coli pathogenic strains during
the summer could explain the seasonality of E. coli, this
hypothesis may be very simplistic. Correlations between
temperature and the incidence of disease may be con-
founded by a huge number of unmeasurable variables [3].
For example, Perencevich [4] suggested that, given the
high incidence of urinary tract infection as the E. coli portal
of entry, increased sexual activity during the summer months
(a known risk factor for community-acquired urinary tract
infection) could explain the seasonal variation found by us
and other authors [4].
Therefore, a seasonal increase in exposure to E. coli is
probably not the only mechanism by which the incidence of
BSI might increase. Seasonal changes in vulnerability to dis-
ease within a population are also possible. These changes
might result from seasonal changes in host immune function,
or seasonal changes in the virulence factors of the microor-
ganisms [3].
As expected, the community use of antimicrobials (mea-
sured as total DDD) was statistically signiﬁcantly higher in
the winter season; however, no statistical correlation was
found between their lower use in summer and the high inci-
dence of E. coli BSI.
Our study has some limitations. First, this is a study con-
ducted in a community low-complexity centre, where two-
thirds of the BSIs are community-acquired. Thus, conclusions
from our study may not be generalizable to other hospitals.
Second, although the Ha’Emek Medical Centre provides most
of the medical and laboratory services in northern Israel, so
we could compare BSI data with temperatures recorded in
our area of inﬂuence, our data would probably not match
the temperature registry in the central and southern regions
of the country; therefore, until more studies are performed,
our ﬁndings should be considered to be limited to our geo-
graphical area.
Third, we did not investigate numerous variables, such as
travel, sexual activity, water consumption, recreational water
exposure, or food preparation practices, that could be con-
founders and change the IR of E. coli BSI.
Future studies are needed to determine the reasons for
the seasonal variation in E. coli BSI. Studies should include
humidity, environmental and animal sources of E. coli,
and human activities, in order to ﬁnd cofactors for this
phenomenon.
Awareness regarding seasonal variation in E. coli BSI,
together with local proﬁles of antimicrobial susceptibility,
could be of relevance at the time of starting empirical antimi-
crobial therapy for Gram-negative BSI.
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